SEC Form 4 · accession 0001209191-17-040794
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Barth
Officer — Chief Medical Officer
Period of report
Jun 15, 2017
Accepted (ET)
Jun 19, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2017 | M | 1,629 | $8.79 | D | 64,184 | D | |
| Common Stock | Jun 19, 2017 | M | 30,000 | $10.00 | A | 94,184 | D | |
| Common Stock | Jun 19, 2017 | S | 30,000 | $10.00 | D | 64,184 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $2.29 | Mar 3, 2014 | M | 30,000 | D | Mar 3, 2015 | Mar 3, 2024 | Common Stock | 30,000 | 111,969 | D |
Explanation of responses
- F1The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2016.